These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15642137

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
    Polzer K, Neubert K, Meister S, Frey B, Baum W, Distler JH, Gückel E, Schett G, Voll RE, Zwerina J.
    Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.
    van de Loo FA, Kuiper S, van Enckevort FH, Arntz OJ, van den Berg WB.
    Am J Pathol; 1997 Jul; 151(1):177-91. PubMed ID: 9212744
    [Abstract] [Full Text] [Related]

  • 27. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis.
    Binder NB, Puchner A, Niederreiter B, Hayer S, Leiss H, Blüml S, Kreindl R, Smolen JS, Redlich K.
    Arthritis Rheum; 2013 Mar; 65(3):608-17. PubMed ID: 23280418
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
    Zhang Q, Badell IR, Schwarz EM, Boulukos KE, Yao Z, Boyce BF, Xing L.
    Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Suppression of p53-dependent senescence by the JNK signal transduction pathway.
    Das M, Jiang F, Sluss HK, Zhang C, Shokat KM, Flavell RA, Davis RJ.
    Proc Natl Acad Sci U S A; 2007 Oct 02; 104(40):15759-64. PubMed ID: 17893331
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. JNK1 is required to preserve cardiac function in the early response to pressure overload.
    Tachibana H, Perrino C, Takaoka H, Davis RJ, Naga Prasad SV, Rockman HA.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1060-6. PubMed ID: 16579967
    [Abstract] [Full Text] [Related]

  • 39. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
    Yao K, Cho YY, Bergen HR, Madden BJ, Choi BY, Ma WY, Bode AM, Dong Z.
    Cancer Res; 2007 Sep 15; 67(18):8725-35. PubMed ID: 17875713
    [Abstract] [Full Text] [Related]

  • 40. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis.
    Zwerina J, Tuerk B, Redlich K, Smolen JS, Schett G.
    Arthritis Res Ther; 2006 Sep 15; 8(1):R22. PubMed ID: 16507121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.